Users Online: 647 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
 

 

Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
     
Year : 2006  |  Volume : 50  |  Issue : 1  |  Page : 43-4

Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.


Dept. of Pathology, NRS Medical College

Correspondence Address:
S Chakrabarti
Dept. of Pathology, NRS Medical College

Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17193761

Rights and PermissionsRights and Permissions

Along with hepatitis B virus (HBV) and human immunodeficiency virus (HIV), Hepatitis C virus (HCV) is emerging as a major transfusion hazard. 22 cases of haemophilia (A 19, B 3) and 20 cases of thalassaemia (2 16, E(2) 4) constituted the study group. Patients tested for anti HCV (using third generation ELISA), HBsAg and antibodies to HIV I and II. Prevalence of anti HCV was 54.5% in haemophilics and 5% in thalassaemics. HBsAg was detected in 9.09% haemophilics and 5% thalassaemics. No anti HIV was detected in this cohort. Anti HCV seropositivity in haemophilics has increased compare to previous studies.


[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed256    
    Printed21    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 6    

Recommend this journal